NFKB1 and Alzheimer disease: EJW treatment reduced these levels (Figures 14D–F), suggesting EJW may mitigate AGEs/RAGE/NF-κB signaling pathway activation, enhancing lipid metabolism and thereby exerting a therapeutic effect on AD.